MedTrace Logo

Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris

NCT02525549 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 903

Last updated 2021-11-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the safety and bioequivalence of Perrigo's product to an FDA approved product for the treatment acne vulgaris.

Conditions

Interventions

DRUG

Adapalene and Benzoyl Peroxide Gel

DRUG

Adapalene and Benzoyl Peroxide Gel (Reference)

DRUG

Placebo gel

Sponsors & Collaborators

  • Padagis LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-08-31
Completion
2012-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02525549 on ClinicalTrials.gov